Developer docs
API playgroundTry for free, no card

Search company profiles

Asia Actual

Full company profile

uuid000l2b3

Namestring
Asia Actual
Legal namestring
Asia Actual LLC
Websiteurl
asiaactual.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Asia Actual is a privately-held professional services firm that acts as the local regulatory representative for medical device and IVD manufacturers seeking market access across 16 Asia Pacific jurisdictions (Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Vietnam, and New Zealand). Its core service suite covers independent license holding (where the manufacturer retains ownership of the registration certificate separate from local commercial partners), device registration and renewals, post-market vigilance, importing and customs clearance, and commercial support. The firm does not develop proprietary technology products; its value is delivered through in-country regulatory experts with an average of 21 years of medical device industry experience.

The company operates from an Americas headquarters in Austin, Texas, with an Asia regional headquarters in Singapore and wholly-owned operating subsidiaries in India, Indonesia, and the Philippines. Headcount is reported in the 11–50 range, and the firm has served over 300 companies from 38 client countries, supporting more than 2,000 registered products. The GTM motion is enterprise field sales to medical device manufacturers needing multi-country APAC clearance, and revenue is generated on a project/consulting-fee basis (professional services model); no public pricing exists. Marketing is driven by an extensive regulatory-updates blog and newsletter covering each APAC market.

The portfolio has expanded beyond core regulatory services into adjacent commercial offerings, including eCommerce platform services (enabling medical device sales on Lazada and Shopee in Southeast Asia), distributor oversight (channel evaluation and KOL engagement), and an in-house platform tool branded R.O.S.E. Ownership is founder-controlled (Bryan Gilburg, Managing Director), with no disclosed institutional funding, parent company, or M&A history.

Short descriptiontext

Asia Actual is a US-domiciled, Singapore-led professional services firm that serves as the local regulatory representative for medical device and IVD manufacturers across 16 Asia Pacific markets, providing registration, independent license holding, post-market vigilance, and customs clearance.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices16 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device registration, regulatory affairs consulting, authorized representative services, independent license holding, market access consulting
NAICS code1 code
  • Professional, Scientific, and Technical Services54
SIC code1 code
  • Services-Health Services8000
Product category
Medical Device Regulatory Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Regulatory Consulting Services
TypeProfessional Services
Description

Professional consulting fees for medical device registration, authorized representative services, independent license holding, post-market vigilance, importing and customs clearance support, and commercial support across Asia Pacific markets.

asiaactual.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1R.O.S.E.
Description

A platform/service offered by Asia Actual for market access solutions.

asiaactual.com
Core offering1 text field

Asia Actual provides medical device registration, authorized representative, and independent license holding services across 16 Asia Pacific markets. The firm acts as the local regulatory representative for medical device and IVD manufacturers, handling registration submissions, post-market vigilance, importing and customs clearance, and commercial/distributor support.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Asia Actual is a medical device regulatory consulting company offering a unified portfolio of regulatory and commercial services across 16 Asia Pacific markets. The core service suite consists of Independent License Holding, Device Registration, Post-Market Vigilance, Importing & Customs Clearance, and Commercial Support. These services are complemented by eCommerce platform services for online sales, Distributor Oversight for sales channel management, and the R.O.S.E. platform tool. The company serves as local regulatory representative providing authorized representative services and independent license holding across Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, New Zealand, and Vietnam.

Product and service7 records
1Independent License Holding
CategoryRegulatory Services
Description

Holds registration certificates on behalf of medical device manufacturers, keeping ownership separate from commercial partners to optimize sales channel management, IP protection, and regulatory support across APAC markets.

2Device Registration
CategoryRegulatory Services
Description

Direct engagement with local regulatory experts in each market to handle medical device and IVD registrations, maintenance, and renewals across Asia Pacific.

3Post-Market Vigilance
CategoryRegulatory Services
Description

Time-sensitive regulatory actions and post-market surveillance managed by experienced regulatory professionals in each market for medical device and IVD manufacturers.

4Importing & Customs Clearance
CategoryLogistics and Import Services
Description

Specialized importing and customs clearance support providing clarity into importing costs and processes to eliminate delays for medical device manufacturers moving products into APAC markets.

5Commercial Support
CategoryCommercial Support Services
Description

Sales channel problem solving and commercial support delivered by seasoned local experts across Asia Pacific markets for medical device manufacturers.

6eCommerce Platform Services
CategoryCommercial Support Services
Description

Comprehensive eCommerce sales program covering store establishment, translation, localization, customer management, inventory, and financial compliance for medical device sales on platforms like Lazada and Shopee in Southeast Asia.

7Distributor Oversight
CategoryCommercial Support Services
Description

Sales channel management service including distributor evaluation, sales call participation, performance reports, coaching, training, and KOL identification in markets such as Malaysia.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Arriello is a regulatory and quality consulting firm for medical devices, IVDs, and combination products, providing authorized representative and registration services across Europe and select global markets. It is directly comparable to Asia Actual as a similarly sized specialist firm offering outsourced regulatory affairs to medtech manufacturers seeking market access.

TypeDirect peer
Description

ProPharma Group is a global regulatory, compliance, and clinical consulting firm serving pharma, biopharma, and medical device companies. It directly competes with Asia Actual in providing outsourced regulatory affairs, quality, and compliance services to medtech manufacturers, with overlapping authorized representative and registration capabilities.

TypeDirect peer
Description

Pacific Bridge Medical is a consultancy that helps medical device, pharmaceutical, and IVD companies navigate regulatory and market access in Asia. It is a direct competitor to Asia Actual, offering similar registration, authorized representative, and distribution support services across Asian markets.

TypeDirect peer
Description

PharmaLex, now part of Cencora (formerly AmerisourceBergen), is a global provider of regulatory, scientific, and compliance services for the pharma and medical device industries. It is a direct peer to Asia Actual in providing outsourced regulatory affairs and market access consulting, with comparable authorized representative services.

5IMed Consultancy
TypeDirect peer
Description

IMed Consultancy is a medical device regulatory affairs consultancy specializing in EU and international market access, offering authorized representative and CE marking services. It is a direct peer to Asia Actual as a similarly focused regulatory consulting firm for medtech manufacturers, though primarily EU-centric.

TypeBroad incumbent
Description

IQVIA is a global CRO and life sciences services giant providing clinical, regulatory, and market access services. It is a broad incumbent competing for the same regulatory consulting and market access budget as Asia Actual, particularly with medtech manufacturers seeking multi-region coverage.

TypeBroad incumbent
Description

ICON is a global CRO offering clinical research and regulatory services to pharma and medical device companies. It competes with Asia Actual at the broader regulatory and market access services layer, particularly for large medtech manufacturers with global rollout needs.

TypeBroad incumbent
Description

Parexel is a global CRO with regulatory consulting and market access offerings across pharma and medtech. It is a broad incumbent peer competing with Asia Actual for large multinational medical device manufacturers seeking full-service regulatory and clinical support.

TypeBroad incumbent
Description

Deloitte's Life Sciences practice offers regulatory strategy, compliance, and market access consulting to pharma and medtech clients globally. It competes with Asia Actual at the higher end of the market, particularly for multinational manufacturers seeking Big-4 scale and integrated services.

TypeDirect peer
Description

RApport Global Strategic Services is a consultancy providing regulatory affairs, quality assurance, and clinical trial services to medical device and pharma companies. It is a direct peer to Asia Actual in providing outsourced regulatory and market access services to medtech manufacturers across international markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Asia Actual

Medical Device Regulatory Consultingasiaactual.com

Asia Actual is a US-domiciled, Singapore-led professional services firm that serves as the local regulatory representative for medical device and IVD manufacturers across 16 Asia Pacific markets, providing registration, independent license holding, post-market vigilance, and customs clearance.

What Asia Actual does

Asia Actual is a privately-held professional services firm that acts as the local regulatory representative for medical device and IVD manufacturers seeking market access across 16 Asia Pacific jurisdictions (Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Vietnam, and New Zealand). Its core service suite covers independent license holding (where the manufacturer retains ownership of the registration certificate separate from local commercial partners), device registration and renewals, post-market vigilance, importing and customs clearance, and commercial support. The firm does not develop proprietary technology products; its value is delivered through in-country regulatory experts with an average of 21 years of medical device industry experience.

The company operates from an Americas headquarters in Austin, Texas, with an Asia regional headquarters in Singapore and wholly-owned operating subsidiaries in India, Indonesia, and the Philippines. Headcount is reported in the 11–50 range, and the firm has served over 300 companies from 38 client countries, supporting more than 2,000 registered products. The GTM motion is enterprise field sales to medical device manufacturers needing multi-country APAC clearance, and revenue is generated on a project/consulting-fee basis (professional services model); no public pricing exists. Marketing is driven by an extensive regulatory-updates blog and newsletter covering each APAC market.

The portfolio has expanded beyond core regulatory services into adjacent commercial offerings, including eCommerce platform services (enabling medical device sales on Lazada and Shopee in Southeast Asia), distributor oversight (channel evaluation and KOL engagement), and an in-house platform tool branded R.O.S.E. Ownership is founder-controlled (Bryan Gilburg, Managing Director), with no disclosed institutional funding, parent company, or M&A history.

Asia Actual firmographics

Firmographics
Name
Asia Actual
Legal name
Asia Actual LLC
Website
https://asiaactual.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Asia Actual is a US-domiciled, Singapore-led professional services firm that serves as the local regulatory representative for medical device and IVD manufacturers across 16 Asia Pacific markets, providing registration, independent license holding, post-market vigilance, and customs clearance.
Ownership category
akta.pro rank

Where Asia Actual is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices16 records

Markets served

Asia Actual business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Regulatory Consulting Services: Professional consulting fees for medical device registration, authorized representative services, independent license holding, post-market vigilance, importing and customs clearance support, and commercial support across Asia Pacific markets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Asia Actual product offering

Product offering

Core offering

Asia Actual provides medical device registration, authorized representative, and independent license holding services across 16 Asia Pacific markets. The firm acts as the local regulatory representative for medical device and IVD manufacturers, handling registration submissions, post-market vigilance, importing and customs clearance, and commercial/distributor support.

Product overview

Asia Actual is a medical device regulatory consulting company offering a unified portfolio of regulatory and commercial services across 16 Asia Pacific markets. The core service suite consists of Independent License Holding, Device Registration, Post-Market Vigilance, Importing & Customs Clearance, and Commercial Support. These services are complemented by eCommerce platform services for online sales, Distributor Oversight for sales channel management, and the R.O.S.E. platform tool. The company serves as local regulatory representative providing authorized representative services and independent license holding across Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, New Zealand, and Vietnam.

Differentiator

Problem solved

Functional benefit

Brands

  • R.O.S.E. A platform/service offered by Asia Actual for market access solutions.

Products and services

  • Independent License Holding Holds registration certificates on behalf of medical device manufacturers, keeping ownership separate from commercial partners to optimize sales channel management, IP protection, and regulatory support across APAC markets.
  • Device Registration Direct engagement with local regulatory experts in each market to handle medical device and IVD registrations, maintenance, and renewals across Asia Pacific.
  • Post-Market Vigilance Time-sensitive regulatory actions and post-market surveillance managed by experienced regulatory professionals in each market for medical device and IVD manufacturers.
  • Importing & Customs Clearance Specialized importing and customs clearance support providing clarity into importing costs and processes to eliminate delays for medical device manufacturers moving products into APAC markets.
  • Commercial Support Sales channel problem solving and commercial support delivered by seasoned local experts across Asia Pacific markets for medical device manufacturers.
  • eCommerce Platform Services Comprehensive eCommerce sales program covering store establishment, translation, localization, customer management, inventory, and financial compliance for medical device sales on platforms like Lazada and Shopee in Southeast Asia.
  • Distributor Oversight Sales channel management service including distributor evaluation, sales call participation, performance reports, coaching, training, and KOL identification in markets such as Malaysia.

Companies that use Asia Actual

Customer profile

Named customers6 records

Segments2 records

Ideal customer profiles1 record

Asia Actual technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Asia Actual partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Asia Actual competitors and assessment

Company assessment

Direct peers

  • Arriello: Arriello is a regulatory and quality consulting firm for medical devices, IVDs, and combination products, providing authorized representative and registration services across Europe and select global markets. It is directly comparable to Asia Actual as a similarly sized specialist firm offering outsourced regulatory affairs to medtech manufacturers seeking market access.
  • ProPharma Group: ProPharma Group is a global regulatory, compliance, and clinical consulting firm serving pharma, biopharma, and medical device companies. It directly competes with Asia Actual in providing outsourced regulatory affairs, quality, and compliance services to medtech manufacturers, with overlapping authorized representative and registration capabilities.
  • Pacific Bridge Medical: Pacific Bridge Medical is a consultancy that helps medical device, pharmaceutical, and IVD companies navigate regulatory and market access in Asia. It is a direct competitor to Asia Actual, offering similar registration, authorized representative, and distribution support services across Asian markets.
  • PharmaLex (Cencora): PharmaLex, now part of Cencora (formerly AmerisourceBergen), is a global provider of regulatory, scientific, and compliance services for the pharma and medical device industries. It is a direct peer to Asia Actual in providing outsourced regulatory affairs and market access consulting, with comparable authorized representative services.
  • IMed Consultancy: IMed Consultancy is a medical device regulatory affairs consultancy specializing in EU and international market access, offering authorized representative and CE marking services. It is a direct peer to Asia Actual as a similarly focused regulatory consulting firm for medtech manufacturers, though primarily EU-centric.
  • RApport Global Strategic Services: RApport Global Strategic Services is a consultancy providing regulatory affairs, quality assurance, and clinical trial services to medical device and pharma companies. It is a direct peer to Asia Actual in providing outsourced regulatory and market access services to medtech manufacturers across international markets.

Broad incumbents

  • IQVIA: IQVIA is a global CRO and life sciences services giant providing clinical, regulatory, and market access services. It is a broad incumbent competing for the same regulatory consulting and market access budget as Asia Actual, particularly with medtech manufacturers seeking multi-region coverage.
  • ICON plc: ICON is a global CRO offering clinical research and regulatory services to pharma and medical device companies. It competes with Asia Actual at the broader regulatory and market access services layer, particularly for large medtech manufacturers with global rollout needs.
  • Parexel: Parexel is a global CRO with regulatory consulting and market access offerings across pharma and medtech. It is a broad incumbent peer competing with Asia Actual for large multinational medical device manufacturers seeking full-service regulatory and clinical support.
  • Deloitte (Life Sciences Regulatory): Deloitte's Life Sciences practice offers regulatory strategy, compliance, and market access consulting to pharma and medtech clients globally. It competes with Asia Actual at the higher end of the market, particularly for multinational manufacturers seeking Big-4 scale and integrated services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Asia Actual social profiles

Digital presence

Asia Actual financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Asia Actual leadership team

Management profile

Number of profiles

Profiles13 records

Asia Actual subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Asia Actual funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Asia Actual M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Asia Actual

What does Asia Actual do?

Asia Actual provides medical device registration, authorized representative, and independent license holding services across 16 Asia Pacific markets. The firm acts as the local regulatory representative for medical device and IVD manufacturers, handling registration submissions, post-market vigilance, importing and customs clearance, and commercial/distributor support.

Is Asia Actual a public or private company?

Asia Actual is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Asia Actual founded?

Asia Actual was founded in 2015. It employs 11 to 50 people.

Where is Asia Actual based?

Asia Actual is headquartered in Austin, United States, in the North America region.

How does Asia Actual make money?

One revenue line is on record: regulatory Consulting Services.

Who are Asia Actual's main competitors?

Direct peers on record are Arriello, ProPharma Group, Pacific Bridge Medical, PharmaLex (Cencora), IMed Consultancy and RApport Global Strategic Services. Broad incumbents are IQVIA, ICON plc, Parexel and Deloitte (Life Sciences Regulatory).

Does Asia Actual have an API?

No public API is recorded for Asia Actual.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales